查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514028

生物成像成像技術的全球市場

BioImaging Technologies
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球生物成像成像技術市場預計將達到 316 億美元

2023年全球生物成像成像技術市場估計為119億美元，預計到2030年將達到316億美元，2023年至2030年複合年成長率為15.0%。醫療技術是本報告分析的細分市場之一，預計複合年成長率為 14.7%，到分析期結束時將達到 195 億美元。分析期間分子技術產業的複合年成長率預計為 15.5%。

美國市場預計33億美元，中國預計複合年成長率14.2%

預計 2023 年美國生物成像成像技術市場規模將達 33 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達48億美元，2023-2030年分析期間複合年成長率為14.2%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 13.0% 和 12.6%。在歐洲，德國預計複合年成長率為 10.7%。

全球成像技術市場—主要趨勢與促進因素總結

成像技術透過即時可視化生物過程，徹底改變了醫學。透過將解剖結構資訊與電場和磁場、機械運動和代謝過程等功能資料相結合，生物成像提供了人體內部運作的全面視圖。 X 光、超音波、MRI 和先進電腦斷層掃描等技術可顯示解剖和細胞結構的詳細影像，對於疾病診斷和管理至關重要。這些非侵入性方法可以在沒有物理侵入的情況下進行詳細檢查，使其在臨床實踐中具有無價的價值。生物影像是一個跨學科領域，它整合了電氣、機械和生物醫學工程來解決複雜的生物學問題，從而在癌症等疾病的理解和治療方面取得了重大進展。

生物成像的進步深深植根於計算生物學和生物資訊學，並專注於細胞和分子影像的高通量分析。現代自動顯微鏡和先進的計算技術提高了資料分析的準確性和效率，同時最大限度地減少了人為干預。多光子成像、影像引導干預和各種顯微鏡技術等創新擴大了醫療診斷和治療計劃的能力。生物成像的關鍵挑戰之一以及影像處理技術的計算複雜性是與影像重建相關的數值不穩定性。最近的趨勢包括整合人工智慧 (AI) 和機器學習，以增強影像分析並將原始資料轉化為可行的醫學見解。

有幾個重要因素促進了成像技術的發展。人工智慧和機器學習的進步可以實現更複雜的分析，提高診斷準確性和效率。增強的運算能力和卓越的演算法可實現更快、更可靠的影像處理。對個人化醫療的需求不斷成長，需要先進的影像技術來根據個人的生理和分子特徵量身定做治療方法。擴大生物醫學研究需要在細胞和分子層面上觀察和分析生物過程，從而推動了對先進成像工具的需求。不斷成長的醫療保健支出，尤其是在新興國家，正在推動生物成像的採用。患者意識的提高和對早期準確診斷的期望，以及支持性監管政策和成像技術成本的降低，正在進一步推動生物成像系統在醫療保健領域的採用。這些因素共同支持了生物成像在現代醫學和科學領域的重要角色。

受訪企業範例（14家知名企業）

  • BioClinica
  • Bracco Imaging SpA
  • Digirad Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM SonoSite, Inc.
  • GE Healthcare
  • Hitachi, Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP-7637

Global BioImaging Technologies Market to Reach US$31.6 Billion by 2030

The global market for BioImaging Technologies estimated at US$11.9 Billion in the year 2023, is expected to reach US$31.6 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2023-2030. Medical Technology, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$19.5 Billion by the end of the analysis period. Growth in the Molecular Technology segment is estimated at 15.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 14.2% CAGR

The BioImaging Technologies market in the U.S. is estimated at US$3.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 14.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Global BioImaging Technologies Market - Key Trends and Drivers Summarized

Bioimaging technologies have revolutionized medical sciences by providing real-time visualization of biological processes. Combining anatomical structure information with functional data such as electrical and magnetic fields, mechanical motion, and metabolic processes, bioimaging offers a comprehensive view of the human body's internal workings. Techniques like X-rays, ultrasound, MRI, and advanced CT scans reveal detailed images of anatomical and cellular structures, crucial for diagnosing and managing diseases. These non-invasive methods allow for detailed examination without physical intrusion, making them invaluable in clinical settings. Bioimaging is an interdisciplinary field integrating electrical, mechanical, and biomedical engineering to address complex biological questions, leading to significant advancements in understanding and treating diseases like cancer.

The advancement of bioimaging is deeply rooted in computational biology and bioinformatics, focusing on high-throughput analysis of cellular and molecular images. Modern automated microscopes and sophisticated computational methods enhance the accuracy and efficiency of data analysis with minimal human intervention. Innovations such as multi-photon imaging, image-guided interventions, and various microscopy techniques have expanded the capabilities of medical diagnostics and therapeutic planning. One critical challenge in bioimaging is the numerical instability associated with image reconstruction, alongside the computational complexity of image processing methods. Recent developments include integrating Artificial Intelligence (AI) and machine learning to enhance image analysis, transforming raw data into actionable medical insights.

Several key factors drive the growth of bioimaging technologies. Advancements in AI and machine learning enable more sophisticated analysis, improving diagnostic accuracy and efficiency. Enhanced computational power and better algorithms allow for faster and more reliable image processing. The increasing demand for personalized medicine necessitates advanced imaging technologies to tailor therapies based on individual physiological and molecular profiles. Expanding biomedical research requires observing and analyzing biological processes at cellular and molecular levels, driving the need for advanced imaging tools. Rising healthcare expenditure, particularly in emerging economies, supports the adoption of bioimaging. Higher patient awareness and expectations for early and accurate diagnoses, along with supportive regulatory policies and cost reductions in imaging technology, further promote the widespread use of bioimaging systems in healthcare. These factors collectively underscore the significant role of bioimaging in modern medical and scientific domains.

Select Competitors (Total 14 Featured) -

  • BioClinica
  • Bracco Imaging SpA
  • Digirad Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM SonoSite, Inc.
  • GE Healthcare
  • Hitachi, Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • BioImaging Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Advanced Diagnostic Imaging Techniques
    • Growth of Chronic Diseases and Aging Population
    • Advancements in Imaging Modalities and Technologies
    • Rising Adoption of Molecular Imaging and PET Scans
    • Impact of COVID-19 Pandemic on BioImaging Market
    • Government Regulations and Standards for Medical Imaging Devices
    • Expansion of BioImaging Applications in Drug Discovery and Development
    • Development of AI and Machine Learning in BioImaging Analysis
    • Consumer Preferences for Non-Invasive Diagnostic Procedures
    • Role of BioImaging in Personalized Medicine and Targeted Therapies
    • Market Penetration of BioImaging in Oncology and Neurology
    • Influence of Technological Innovations on BioImaging Accuracy and Speed
    • Growth of BioImaging in Academic and Research Institutions
    • Challenges Related to Data Management and Storage in BioImaging
    • Emerging Markets and Growth Opportunities in Developing Regions
    • Future Trends and Innovations in BioImaging Technologies and Applications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for BioImaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for BioImaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for BioImaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Molecular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World BioImaging Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CHINA
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for BioImaging Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for BioImaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Europe 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Asia-Pacific 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of World 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030

IV. COMPETITION